1 |
3D Medicines Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
2 |
Abbisko Cayman Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
3 |
AbClon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
4 |
Abnova Taiwan Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
5 |
ABPRO Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
6 |
Aceragen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
7 |
Acorda Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
8 |
Acrobiosystems Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
9 |
Adimmune Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
10 |
ADMA Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
11 |
Advicenne SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
12 |
Agenus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
13 |
AIM ImmunoTech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
14 |
AIM Vaccine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
15 |
ALK-Abello A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
16 |
Alpha Teknova Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
17 |
Alteogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
18 |
Amgen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
19 |
Anhui Anke Biotechnology Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
20 |
ANI Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
21 |
Apellis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
22 |
Appili Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
23 |
AprilBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
24 |
Aptahem AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
25 |
Aptose Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
26 |
Arctic Bioscience AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
27 |
Armata Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
28 |
Aroa Biosurgery Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
29 |
Atect Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
30 |
Bavarian Nordic A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
31 |
Beijing Biostar Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
32 |
Beijing Bohui Innovat Biotech Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
33 |
Beijing Health Guard Biotechnology Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
34 |
Beijing Luzhu Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
35 |
Beijing Scitop Bio-tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
36 |
Beijing SL Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
37 |
Beijing Tiantan Biological Products Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
38 |
Beijing Wantai Biolog Pha Ent Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
39 |
Bicara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
40 |
Bio Solution Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
41 |
BIO-TECHNE Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
42 |
Bioatla Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
43 |
BioCardia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
44 |
Biocon Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
45 |
BioCryst Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
46 |
Biocytogen Pharmaceuticals Beijng Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
47 |
BioGaia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
48 |
Biogen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
49 |
BioPlus Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
50 |
Bloomage Biotechnology Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
51 |
Bolt Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
52 |
Bonesupport Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
53 |
Brainstorm Cell Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
54 |
Calidi Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
55 |
Cansino Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
56 |
Cara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
57 |
Cardiff Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
58 |
CARsgen Therapeutics Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
59 |
CASI Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
60 |
CEL-SCI Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
61 |
Cell Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
62 |
Cellid Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
63 |
Celltrion HealthCare Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
64 |
Celltrion Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
65 |
Cellumed Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
66 |
CERo Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
67 |
CHA Vaccine Research Institute (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
68 |
Champions Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
69 |
Changchun BCHT Biotechnology Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
70 |
Chengdu Kanghong Pharma Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
71 |
Chengdu Kanghua Biological Prdcts Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
72 |
Chengdu Olymvax Biopharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
73 |
Chimeric Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
74 |
China Resrcs Boya Bio phrmctcl Grp CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
75 |
CHO Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
76 |
Chongqing Genrix Biophrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
77 |
Chongqing Zhifei Biological Prdct Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
78 |
Choong Ang Vaccine Laboratory (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
79 |
Chosa Oncology AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
80 |
Circa Group AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
81 |
Coherus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
82 |
Compugen Ltd (USA) (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
83 |
Cuorips Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
84 |
Curatis Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
85 |
Curis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
86 |
Denali Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
87 |
EirGenix Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
88 |
Elutia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
89 |
Ensol Biosciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
90 |
Enzon Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
91 |
ESG Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
92 |
Essex Bio-Technology Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
93 |
EuBiologics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
94 |
Eutilex Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
95 |
Ever Supreme Bio Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
96 |
ExpreS2ion Biotech Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
97 |
Exscientia PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
98 |
Fate Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
99 |
Fennec Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
100 |
Fermenta Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
101 |
Forma Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
102 |
Formosa Pharmaceuticals Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
103 |
Fortress Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
104 |
Fresh Tracks Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
105 |
GC Biopharma Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
106 |
Gene One Life Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
107 |
Genfit SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
108 |
Genflow Biosciences PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
109 |
Gilead Sciences, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
110 |
Green Cross WellBeing Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
111 |
Green Planet Bioengineering Co Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
112 |
Grifols SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
113 |
Gritstone bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
114 |
Guangdong VTR Bio-Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
115 |
Guangdong Winsun Bio-Phrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
116 |
Halozyme Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
117 |
Hebei Changshan Biochemical Pharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
118 |
Helixmith Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
119 |
Heska Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
120 |
Hims & Hers Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
121 |
Hualan Biological Engineering Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
122 |
Hualan Biological Vaccine Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
123 |
Hugel Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
124 |
Humacyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
125 |
Immix Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
126 |
Immunocore Holdings PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
127 |
Immunoprecise Antibodies Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
128 |
Immuron Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
129 |
Innate Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
130 |
Innovent Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
131 |
Intervacc AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
132 |
Inventage Lab Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
133 |
Ipsen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
134 |
Isu Abxis Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
135 |
J2KBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
136 |
Jiangsu Aidea Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
137 |
Jiangsu gdk Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
138 |
Jiangsu Recbio Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
139 |
Jiangsu Sihuan Bioengineering Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
140 |
Jinyu Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
141 |
Kaleido Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
142 |
Kamada Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
143 |
Kedrion SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
144 |
Kexing Biopharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
145 |
Keymed Biosciences Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
146 |
Komipharm International Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
147 |
LadRx Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
148 |
LakeShore Biopharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
149 |
Liaoning Cheng Da Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
150 |
Liaoning Chengda Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
151 |
Lineage Cell Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
152 |
Mabpharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
153 |
Mabwell Shanghai Bioscience Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
154 |
Marinomed Biotech AG (Austria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
155 |
MaxCyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
156 |
Medigen Vaccine Biologics Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
157 |
Medincell SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
158 |
Medy Tox Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
159 |
MeiraGTx Holdings PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
160 |
Metagenomi Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
161 |
Microbot Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
162 |
MicroPort NeuroScientic Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
163 |
Moa Life Plus (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
164 |
Molecure SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
165 |
Mycenax Biotech Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
166 |
Mymetics Corp (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
167 |
Neurocrine Biosciences, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
168 |
NewAmsterdam Pharma Company NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
169 |
Nha Trang Vccns nd Blgcl Prdcts JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
170 |
Nibec Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
171 |
NKGen Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
172 |
Novavax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
173 |
Novocure Ltd (Jersey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
174 |
Novoprotein Scientific Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
175 |
NS Wind Down Co Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
176 |
Numeral Ltd (Mauritius) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
177 |
Nxera Pharma Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
178 |
Obio Technology Shanghai Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
179 |
Octapharma AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
180 |
Ocugen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
181 |
Onconetix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
182 |
Oncotelic Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
183 |
Orchard Therapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
184 |
Organovo Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
185 |
Ouro Fino Saude Animal Participacoes SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
186 |
Pacific Shuanglin Bio-pharmacy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
187 |
PDL BioPharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
188 |
Peptron Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
189 |
Perseus Proteomics Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
190 |
Phaxiam Therapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
191 |
Plumbline Life Sciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
192 |
Pluri Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
193 |
Prebona AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
194 |
Precigen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
195 |
Prolight Diagnostics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
196 |
Protalix Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
197 |
Pulike Biological Engineering Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
198 |
Qiagen NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
199 |
Qingdao Vland Biotech INC (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
200 |
Quratis Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
201 |
Reber Genetics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
202 |
Regenerative Medical Technology Grop Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
203 |
Relay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
204 |
RemeGen Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
205 |
Repligen Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
206 |
RTA Lbrtvrlr Byljk rnlr lc v Mkn Sny Tcr (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
207 |
S Biomedics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
208 |
Samsung Biologics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
209 |
Sangamo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
210 |
Scandion Oncology A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
211 |
SciClone Pharmaceuticals (Holdings) Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
212 |
SCL Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
213 |
Seagen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
214 |
Shandong Boan Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
215 |
Shandong Sinobioway Biomedicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
216 |
Shanghai Haoyuan Chemexpress Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
217 |
Shanghai Henlius Biotech Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
218 |
Shanghai Hile Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
219 |
Shanghai Junshi Biosciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
220 |
Shanghai OPM Biosciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
221 |
Shanghai RAAS Blood Products Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
222 |
Shanghai Serum Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
223 |
Shenzhen Kangtai Biological Prods Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
224 |
Shenzhen Weiguang Biologcl Prdcts Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
225 |
SinoMab Bioscience Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
226 |
SK Bioscience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
227 |
SL Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
228 |
Solid Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
229 |
Staidson Beijing BioPharmaceutcls Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
230 |
Sunshine Guojian Pharmcutcl Shngh Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
231 |
Sutro Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
232 |
SynAct Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
233 |
SynCore Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
234 |
Synthaverse SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
235 |
Taiwan Advance Bio-Pharmaceutical Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
236 |
Tego Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
237 |
Tevogen Bio Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
238 |
Third Harmonic Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
239 |
Tianjin Ringpu Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
240 |
Titan Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
241 |
Titan Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
242 |
Tonghua Dongbao Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
243 |
Transcenta Holding Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
244 |
Transgene SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
245 |
Tscan Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
246 |
Turnstone Biologics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
247 |
Twist Bioscience Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
248 |
U-Neuron Biomedical Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
249 |
UCB SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
250 |
Ultimovacs ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
251 |
Vaxart Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
252 |
Vectorite Biomedical Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
253 |
Vericel Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
254 |
Vitro Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
255 |
Walvax Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
256 |
Windtree Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
257 |
Woojung BIO Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
258 |
WuXi Biologics (Cayman) Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
259 |
WuXi XDC Cayman Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
260 |
Xcell Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
261 |
Xiamen Amoytop Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
262 |
Xtant Medical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
263 |
Zhong Yuan Bio-Technology Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |